APP下载

丁苯酞注射液联合依达拉奉对急性脑梗死患者缺血再灌注损伤的预防作用

2020-12-23张松

中外医疗 2020年17期

张松

[摘要] 目的 分析依达拉奉联合丁苯酞注射液在预防急性脑梗死患者缺血再灌注损伤的临床效果。方法 便利选取2019年1—6月该院收治的70例急性脑梗死的患者作为研究对象,将其随机均分为依达拉奉组35例和联合治疗组35例,对照组采用给予依达拉奉治疗,观察组在上述治疗的基础上联合丁苯酞注射液进行治疗,对比观察两组患者NIHSS量表评分、Barthel指数评分、临床效果及不良反应发生率。结果 治疗后两组患者NIHSS均下降,且联合治疗组更低,差异有统计学意义(P<0.05)。联合治疗组治疗有效率(94.29%)明显高于依达拉奉组治疗有效率(62.86%),差异有统计学意义(χ2=8.485,P=0.004)。两组患者不良反应发生率比较,差异无统计学意义(χ2=0.117,P=0.734)。 结论 依达拉奉联合丁苯酞注射液可以明显改善急性脑梗死患者缺血再灌注损伤临床疗效,加快脑功能的恢复,值得推广应用。

[关键词] 依达拉奉;丁苯酞;急性脑梗死;缺血再灌注损伤;临床效果

[中图分类号] R743.3          [文献标识码] A          [文章编号] 1674-0742(2020)06(b)-0115-03

[Abstract] Objective To analyze the clinical effect of edaravone combined with butylphthalide injection in preventing ischemia-reperfusion injury in patients with acute cerebral infarction. Methods Seventy patients with acute cerebral infarction admitted in our hospital from January 2019 to June 2019 were convenient selected as the research object, and they were randomly divided into 35 cases in the edaravone group and 35 cases in the combined treatment group. The control group was given edaravone treatment, the observation gro\\\\\\\p was treated with butylphthalide injection on the basis of the above treatment, and the NIHSS scale score, Barthel index score, clinical effect, and incidence of adverse reactions were compared between the two groups. Results After treatment, the NIHSS scores of the two groups of patients decreased, and the combined treatment group was lower, the difference was significant(P<0.05). The treatment efficiency in the combination therapy group (94.29%) was significantly higher than that in the edaravone group(62.86%), and the difference was significant (χ2=8.485, P=0.004). The incidence of adverse reactions between the two groups was not significant(χ2=0.117, P=0.734). Conclusion Edaravone combined with butylphthalide injection can significantly improve the clinical effect of ischemia-reperfusion injury in patients with acute cerebral infarction and accelerate the recovery of brain function, which is worthy of popularization and application.

[Key words] Edaravone; Butylphthalide; Acute cerebral infarction; Ischemia-reperfusion injury; Clinical effect

急性腦梗死严重危害着人类的健康,该病不仅仅是发病急,而且发病的原因和机制都很复杂,在临床上主要有发病、致死以及病死率高的特点,而且治愈的可能性小,因此寻找有效的治疗药物,及时采取防治措施,对临床工作和医学研究有重要价值[1-2]。临床数据研究发现,越来越多的急性脑梗死患者通过静脉溶栓治疗后发生严重的脑功能障碍,这其中大多患者的发病原因和梗死病灶发生缺血再灌注损伤。缺血再灌注损伤主要是因为脑梗死病灶恢复供血后,大量的自由基攻击病灶周围的细胞、组织,损伤其组织及神经功能的现象。因此如何保护脑梗死病灶恢复供血后组织及细胞功能不受损伤是治疗缺血再灌注损伤的关键[3-4]。该研究便利选取2019年1—6月该院收治的70例急性脑梗死的患者作为研究对象,观察依达拉奉联合丁苯酞注射液在预防急性脑梗死患者缺血再灌注损伤的临床效果,旨在为临床治疗该类患者提供理论依据,现报道如下。……

登录APP查看全文